
- 100 free trades signup offer
- Easy-to-use platform
- Low fees
- Student and young investor discounts
STERIS is a medical devices business based in the US. STERIS shares (STE) are listed on the NYSE and all prices are listed in US Dollars.
Its last market close was $231.53 – a decrease of 0.31% over the previous week. STERIS employs 18,000 staff and has a trailing 12-month revenue of around $5.4 billion.Note: The dollar amounts in the table below are in Canadian dollars.
To make comparing even easier we came up with the Finder Score. Trading costs, account fees and features across 10+ stock trading platforms and apps are all weighted and scaled to produce a score out of 10. The higher the score the better the platform - simple.
Latest market close | $231.53 |
---|---|
52-week range | $196.38 - $247.59 |
50-day moving average | $216.27 |
200-day moving average | $224.29 |
Wall St. target price | $250.11 |
PE ratio | 37.418 |
Dividend yield | $2.18 (0.98%) |
Earnings per share (TTM) | $6.22 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $231.53 from 2025-03-10
1 week (2025-03-06) | -0.31% |
---|---|
1 month (2025-02-14) | 5.56% |
3 months (2024-12-13) | 8.08% |
6 months (2024-09-13) | -5.43% |
1 year (2024-03-13) | -0.97% |
---|---|
2 years (2023-03-13) | 31.82% |
3 years (2022-03-11) | 8.67% |
5 years (2020-03-13) | 77.43% |
Valuing STERIS stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of STERIS's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
STERIS's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 37x. In other words, STERIS shares trade at around 37x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the stock or simply that they're over-valued.
STERIS's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 5.3074. A low ratio can be interpreted as meaning the stocks offer better value, while a higher ratio can be interpreted as meaning the stocks offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into STERIS's future profitability. By accounting for growth, it could also help you if you're comparing the stock prices of multiple high-growth companies.
STERIS's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $1.4 billion.
The EBITDA is a measure of a STERIS's overall financial performance and is widely used to measure a its profitability.
Revenue TTM | $5.4 billion |
---|---|
Operating margin TTM | 18.33% |
Gross profit TTM | $2.4 billion |
Return on assets TTM | 5.59% |
Return on equity TTM | 9.61% |
Profit margin | 8.66% |
Book value | $65.31 |
Market Capitalization | $22.9 billion |
TTM: trailing 12 months
Dividend payout ratio: 18.08% of net profits
Recently STERIS has paid out, on average, around 0% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), STERIS shareholders could enjoy a 0% return on their shares, in the form of dividend payments. In STERIS's case, that would currently equate to about $2.18 per share.
While STERIS's payout ratio might seem low, this can signify that STERIS is investing more in its future growth.
STERIS's most recent dividend payout was on 20 March 2025. The latest dividend was paid out to all shareholders who bought their stocks by 19 February 2025 (the "ex-dividend date").
STERIS's stocks were split on a 2:1 basis on 24 August 1998 . So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your STERIS stocks – just the quantity. However, indirectly, the new 50% lower stock price could have impacted the market appetite for STERIS stocks, which in turn could have impacted STERIS's stock price.
Over the last 12 months, STERIS's stocks have ranged in value from as little as $196.3788 up to $247.5882. A popular way to gauge a stock's volatility is its "beta."
Beta is a measure of a stocks volatility in relation to the market. The market (NYSE average) beta is 1, while STERIS's is 0.92. This would suggest that STERIS's stocks are less volatile than average (for this exchange).
STERIS plc provides infection prevention products and services worldwide. It operates through three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument, devices, and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The AST segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of contract sterilization and laboratory facilities, as well as integrated sterilization equipment and control systems to medical device manufacturers and research institutions. The Life Sciences segment designs, manufactures, and sells consumable products, such as pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services.
Want to dive into investing but don’t have much to spend? Take a look at these types of stocks.
Read more…Meme stocks can produce large gains in short periods, but the stocks are volatile.
Read more…Your guide to how ETFs work and whether this type of investment is right for you.
Read more…Steps to buying Coinbase stock in Canada with 24-hour and historical pricing before you buy.
Find out how the Trump tariffs will impact the stock market and explore Canadian stocks that may be resilient amidst tariffs.
DeepSeek isn’t publicly traded, but you can invest in similar companies or swoop in on stocks impacted by the DeepSeek effect.
Is Moomoo Canada worth it? In this review, we break down Moomoo’s fees, features, pros and cons.
Enjoy perks like free trades and cash back when you open a stock trading account with these online broker promotions.
What’s the best way to invest money in Canada? Find out how to invest money via stocks, bonds, index funds and more.
These are the best renewable energy stocks to buy now in Canada.
Finder’s unique algorithm found the 20 best TSX stocks to buy right now.
Find out how to invest in the S&P 500 in Canada—one of the world’s most popular stock indices—to diversify your portfolio.
Questrade is a leader among Canadian discount brokerages, but is it right for you? Compare fees, features and alternatives here.